FDA Documents of Chongqing Daxin Pharmaceutical Co., Ltd.
Chongqing Daxin Pharmaceutical Co., Ltd. is an organization that has been audited by the FDA 12 times between 2001 and 2024 across all 5 sites.
Documents
FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Beibei | 2024
Out-of-stock
Issued on: Jun 28, 2024
Human Drugs Form 483
FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Chongqing | 2018
Out-of-stock
Issued on: May 11, 2018
Human Drug Form 483
FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Chongqing | 2009
Out-of-stock
Issued on: Aug 6, 2009
Human Drug Form 483
FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd., Chongqing | 2001
Out-of-stock
Issued on: Sep 25, 2001
Human Drug Form 483
FDA Investigators(10)
- Gavin T. Cua, FDA Investigator
- Joel D. Hustedt, FDA Investigator
- Sony Mathews, FDA Investigator
- Paul L. Bellamy, FDA Investigator
- Larry K. Austin, FDA Investigator
- Susan W. Ting, FDA Investigator
- Jose R. Hernandez, FDA Investigator
- Zi-Qiang Gu, FDA Investigator
- Charles M. Edwards, FDA Investigator
- Yvette I. Johnson, FDA Investigator